Acute Herpes Zoster Neuropathy
Conditions
Brief summary
Acute herpes zoster pain is very severe . Conventional analgesics may be of no value. Regional blocks may play a role
Interventions
Ultrasound guided thoracic erector spinae block
Ultrasound guided serratus anterior block
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult population between 30 and 75 years old. * Unilateral painful thoracic herpetic eruption of less than one week duration. * VAS more than or equal 4, persistent pain in spite of proper antiviral and analgesic therapy, (800 mg oral acyclovir, 5 times per day, for one week), pregabalin 300 mg per day, acetaminophen 1000 mg per day, topical calamine lotion).
Exclusion criteria
* Diabetic patients. * Painful herpetic eruptive vesicles more than one week. * Abdominal herpetic eruptions. * Non-compliant on anti-viral (bulbar palsy for example). * Co-malignancy or radiotherapy. * Steroid therapy \> 5 mg prednisolone or its equivalent. * Infections or hematoma at site of injection. * Coagulopathy (chronic kidney or liver disease, clopidogrel use).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain score | immediate after injection, 1 week, 1, 3 months | Visual analogue scale from 0 to 10. 0= NO pain, 1-3=mild tolerable pain, 4-6= moderate pain, 7-10= severe untearable pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of treatment related adverse events | immediately after injection | hypotension, bradyarrhythmia, hematoma |
| Number of patients with pain recurrence | 1 week, 1, and 3 months | Number of patients in need for re-injection |
| analgesic consumption | 1 week, 1, and 3 months | total amount dose of analgesics used |